Changing innovation in the pharmaceutical industry : globalization and new ways of drug development

書誌事項

Changing innovation in the pharmaceutical industry : globalization and new ways of drug development

Andre Jungmittag, Guido Reger, Thomas Reiss (eds.)

Springer, c2000

  • : hbk

大学図書館所蔵 件 / 11

この図書・雑誌をさがす

注記

Bibliography: p. [187]-195

内容説明・目次

内容説明

The internationalization of research and technology is one key component of the globalization of trade and business, with potentially major impacts on patterns of economic development and public policies worldwide. Although certain aspects of this internationalization trend are well documented, and some effects can be quantified, the overall processes are extremely complex and the outcomes are highly uncertain. The existence of the phenomenon is generally accepted, but its importance and the trends are currently the topic of a lively debate. This study on "New Ways in Drug Development in Pharmaceuticals" is part of a three year project which aims at investigating how new concepts of industrial knowledge creation are implemented in the different environ ments of the innovation systems of the United States and Germany. The main focus of the overall project is a series of case studies of innovation practice in different national and sectoral contexts. The following sectors and technological fields are investigated: pharmaceuticals and new ways in drug development by the Fraunhofer Institute for Systems and Innovation Research (ISI), advanced materials by the University Hohenheim, Insti tute of International Management and Innovation (Alexander Gerybadze), financial services and home banking by the Massachusetts Institute of Tech nology (MIT), Center for Industrial Performance (Richard Lester) and the Sloan School of Management (Edward Roberts). Financially the project was supported by the German-American Academic Council, the German Federal Minstry of Education, Science Research and Technology and the Fraunhofer Society.

目次

A. Jungmittag, G. Reger, T. Reiss: Introduction.- New Ways in Drug Development: Changes of the Locus of Innovation.- Research Approach.- A. Jungmittag: The National System of Innovation in the United States in Germany.- The Concept of the 'Systems of Innovation' Approach.- Systems of Innovation in the German and US Pharmaceutical Sector.- A. Jungmittag, G. Reger: Dynamics of the Markets and Market Structure.- Introduction: Market Categories and Structure.- Production, Consumption and Employment.- Foreign Trade and Foreign Direct Investment.- Conclusions for the International Competitiveness of Selected Countries.- T. Reiss, S. Hinze: Innovation Process and Techno-scientific Dynamics.- Innovation Process in Pharmaceuticals.- Techno-Scientific Changes.- A. Hullmann: Generation, Transfer and Exploitation of New Knowledge.- Changes in the Division of Labor.- Alliances of Pharmaceutical Firms.- Results of the Empirical Analyses.- Conclusions.- G. Reger: Internationalization of Research and Development in Pharmaceuticals.- Introduction.- R&D and Technological Specialization on Country Level.- Internationalization Strategies of Selected Pharmaceutical Companies.- Conclusions.- S. Hinze, T. Reiss: Case Study on New Therapies for Selected Autoimmune Diseases.- Introduction.- Statistical Analysis.- Core Success Factors for Companies in this Field.- Internationalization and Cooperation.- New Distribution of Roles in the R&D Process.- Conclusions.- A. Jungmittag, G. Reger, T. Reiss: Summary and Conclusions.- Changes in the Innovation Process and Conclusions for R&D-performing Actors.- Conclusions for Research and Technology Policy.

「Nielsen BookData」 より

詳細情報

ページトップへ